AmigoMCGoycochea-RoblesMVEspinosa-CuervoG. Development and initial validation of a damage index (DIAPS) in patients with thrombotic antiphospholipid syndrome (APS). Lupus2015; 24: 927–934.
2.
HoeperMMBogaardHJCondliffeR. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol2013; 62: D42–D50.
3.
GalièNHoeperMMHumbertM. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J2009; 30: 2493–2537.
4.
GalièNHumbertMVachieryJL. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J2015; 46: 903–975.
KovacsGBergholdAScheidlSOlschewskiH. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J2009; 34: 888–894.
7.
HervePLauEMSitbonO. Criteria for diagnosis of exercise pulmonary hypertension. Eur Respir J2015; 46: 728–737.
8.
GladmanDGinzlerEGoldsmithC. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum1996; 39: 363–369.
9.
CrowtherMAGinsbergJSJulianJ. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med2003; 349: 1133–1138.
10.
FinazziGMarchioliRBrancaccioV. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost2005; 3: 848–853.
